Universitätsklinikum Heidelberg

Hospital


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000103284908

ROR: https://ror.org/013czdx64

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update (2021) Friedrich M, Kühn T, Janni W, Müller V, Banys-Pachulowski M, Kolberg-Liedtke C, Jackisch C, et al. Journal article, Review article Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK) - Teil 2: „Durchführung der perkutanen Koronarintervention“ (2021) Nef HM, Achenbach S, Birkemeyer R, Bufe A, Doerr O, Elsaesser A, Gaede L, et al. Journal article Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia (2021) Stasik S, Eckardt JN, Kramer M, Roellig C, Kraemer A, Scholl S, Hochhaus A, et al. Journal article Innovative radiation oncology Together - Precise, Personalized, Human Vision 2030 for radiotherapy & radiation oncology in Germany (2021) Krug D, Hecht M, Ebert N, Maeurer M, Fleischmann DF, Fokas E, Straube C, et al. Journal article MSI testing What's new? What should be considered? (2021) Rueschoff J, Baretton G, Blaeker H, Dietmaier W, Dietel M, Hartmann A, Horn LC, et al. Journal article, Review article A learning robot for cognitive camera control in minimally invasive surgery (2021) Wagner M, Bihlmaier A, Kenngott HG, Mietkowski P, Scheikl PM, Bodenstedt S, Schiepe-Tiska A, et al. Journal article Fatigue and Atopic Dermatitis: Results from the German Atopic Dermatitis Registery TREATgermany (2021) Helmert C, Haufe E, Abraham S, Heratizadeh A, Harder , Kleinheinz A, Wollenberg A, et al. Conference contribution An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2021) Ahrens M, Escudier B, Haanen JBAG, Boleti E, Goupil GM, Grimm MO, Negrier S, et al. Conference contribution Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Henes J, Kortus-Goetze B, Kallinich T, Oommen PT, Rech J, Weller-Heinemann F, et al. Conference contribution Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS)-30-months Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Kortus-Goetze B, Oommen PT, Janda A, Rech J, Kallinich T, Weller-Heinemann F, et al. Conference contribution